Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Disease Awareness Ad Policy Is Unfair To Small Firms, BIO Says

Executive Summary

Restrictions on disease awareness advertisements proposed by FDA will hurt small biotech firms, the Biotechnology Industry Organization said
Advertisement

Related Content

Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA
Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA
Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
Ads Linking “Help-Seeking” and Full Product Spots Helps Consumers – Pfizer
DTC Guidance Should Include “Consumerized” Risk Terms, AstraZeneca Says
DTC Comments Support FDA’s Goals; PhRMA Watching “Boundaries”
Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages
Disease Awareness Ad Guidance Stresses Need For “Distinct” Messages
Advertisement
UsernamePublicRestriction

Register

PS044109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel